Hospira irinotecan hydrochloride trihydrate IV Infusion 100 mg
देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
सार्वजनिक आकलन रिपोर्ट
(PAR)
27-11-2017
अनुरोध भेजा।
सक्रिय संघटक:
irinotecan hydrochloride trihydrate, Quantity: 20 mg/mL
थमां उपलब्ध:
Hospira Australia Pty Ltd
INN (इंटरनेशनल नाम):
irinotecan hydrochloride trihydrate
फार्मास्यूटिकल फॉर्म:
Injection, intravenous infusion
रचना:
Excipient Ingredients: lactic acid; sorbitol; water for injections
प्रशासन का मार्ग:
Intravenous Infusion
पैकेज में यूनिट:
1 x 5 mL vial
वर्ग:
Medicine Listed (Export Only)
प्रिस्क्रिप्शन प्रकार:
(S1) This Schedule is intentionally blank
चिकित्सीय संकेत:
Small cell lung carcinoma, non-small cell lung carcinoma, cervical carcinoma, ovarian cancer, stomach cancer (inoperable or recurrent), colorectal cancer (inoperable or recurrent), breast cancer (inoperable or recurrent), squamous cell carcinoma, malignant lymphoma (non Hodgkin's disease).
उत्पाद समीक्षा:
Visual Identification: A clear, colourless to pale yellow solution; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Room temperature; Container Closure: Neither child resistant closure nor restricted flow insert
प्राधिकरण का दर्जा:
Licence status A
प्राधिकरण की तारीख:
2013-01-31
